Terms: = Head and neck cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184
296 results:
1. Exploring Potential Biomarkers in Oesophageal cancer: A Comprehensive Analysis.
Romanowicz A; Lukaszewicz-Zajac M; Mroczko B
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673838
[TBL] [Abstract] [Full Text] [Related]
2. The cxcr4 might be a potential biomarker for esophageal squamous cell carcinoma: A meta-analysis.
Chen P; Zhang YL; Zhang XL; Guo Y; Tang PP
Medicine (Baltimore); 2024 Apr; 103(14):e37681. PubMed ID: 38579048
[TBL] [Abstract] [Full Text] [Related]
3. SOX2 promotes a cancer stem cell-like phenotype and local spreading in oral squamous cell carcinoma.
Sacco A; Battaglia AM; Santamaria G; Buffone C; Barone S; Procopio A; Lavecchia AM; Aversa I; Giorgio E; Petriaggi L; Cristofaro MG; Biamonte F; Giudice A
PLoS One; 2023; 18(12):e0293475. PubMed ID: 38096163
[TBL] [Abstract] [Full Text] [Related]
4. Single-cell RNA-seq reveals MIF-(CD74 + cxcr4) dependent inhibition of macrophages in metastatic papillary thyroid carcinoma.
Chen W; Yu X; Li H; Yuan S; Fu Y; Hu H; Liu F; Zhang Y; Zhong S
Oral Oncol; 2024 Jan; 148():106654. PubMed ID: 38061122
[TBL] [Abstract] [Full Text] [Related]
5. NAD pool as an antitumor target against cancer stem cells in head and neck cancer.
Navas LE; Blanco-Alcaina E; Suarez-Martinez E; Verdugo-Sivianes EM; Espinosa-Sanchez A; Sanchez-Diaz L; Dominguez-Medina E; Fernandez-Rozadilla C; Carracedo A; Wu LE; Carnero A
J Exp Clin Cancer Res; 2023 Mar; 42(1):55. PubMed ID: 36864434
[TBL] [Abstract] [Full Text] [Related]
6. Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Esophageal Squamous Cell Carcinoma.
Jia Y; Zhang B; Zhang C; Kwong DL; Chang Z; Li S; Wang Z; Han H; Li J; Zhong Y; Sui X; Fu L; Guan X; Qin Y
Adv Sci (Weinh); 2023 Mar; 10(7):e2204565. PubMed ID: 36709495
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic Value of WNT1, NOTCH1, PDGFRβ, and cxcr4 in Oral Squamous Cell Carcinoma.
Cierpikowski P; Lis-Nawara A; Bar J
Anticancer Res; 2023 Feb; 43(2):591-602. PubMed ID: 36697060
[TBL] [Abstract] [Full Text] [Related]
8. Exosomal miR-655-3p inhibits growth, and invasion and macrophage M2 polarization through targeting cxcr4 in papillary thyroid carcinoma.
Qiao L; Dong C; Jia W; Ma B
Acta Biochim Pol; 2022 Dec; 69(4):773-779. PubMed ID: 36512648
[TBL] [Abstract] [Full Text] [Related]
9. Differentially Infiltrated Identification of Novel Diagnostic Biomarkers Associated with Immune Infiltration in Nasopharyngeal Carcinoma.
Gao P; Lu W; Hu S; Zhao K
Dis Markers; 2022; 2022():3934704. PubMed ID: 36438903
[TBL] [Abstract] [Full Text] [Related]
10. The prognostic significance of cxcr4 and SDF-1 in differentiated thyroid cancer depends on CD8+ density.
Wilhelm A; Lemmenmeier I; Lalos A; Posabella A; Kancherla V; Piscuoglio S; Delko T; von Flüe M; Glatz K; Droeser RA
BMC Endocr Disord; 2022 Nov; 22(1):292. PubMed ID: 36419107
[TBL] [Abstract] [Full Text] [Related]
11. CXCL12 is expressed by skeletal muscle cells in tongue oral squamous cell carcinoma.
Yorozu A; Sekiguchi S; Takasawa A; Okazaki F; Niinuma T; Kitajima H; Yamamoto E; Kai M; Toyota M; Hatanaka Y; Nishiyama K; Ogi K; Dehari H; Obata K; Kurose M; Kondo A; Osanai M; Miyazaki A; Takano K; Suzuki H
Cancer Med; 2023 Mar; 12(5):5953-5963. PubMed ID: 36300800
[TBL] [Abstract] [Full Text] [Related]
12. Transcriptome reprogramming of Epstein-Barr virus infected epithelial and B cells reveals distinct host-virus interaction profiles.
Ma N; Lu J; Pei Y; Robertson ES
Cell Death Dis; 2022 Oct; 13(10):894. PubMed ID: 36272970
[TBL] [Abstract] [Full Text] [Related]
13. MT1X is an oncogene and indicates prognosis in ccRCC.
Ding Y; Fang J; Chen M; Xu Y; Liu N; Fang S; Xiang W; Chen R; Wu C; Yu H
Biosci Rep; 2022 Oct; 42(10):. PubMed ID: 36149322
[TBL] [Abstract] [Full Text] [Related]
14. Oxymatrine suppresses oral squamous cell carcinoma progression by suppressing CXC chemokine receptor 4 in an m
Luo R; Xie L; Lin Y; Shao J; Lin Z
Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36004481
[TBL] [Abstract] [Full Text] [Related]
15. FOXA2 promotes esophageal cancer migration and metastasis by activating cxcr4 expression.
Chen Z; Xiao Q; Shen Y; Xue C
Biochem Biophys Res Commun; 2022 Oct; 625():16-22. PubMed ID: 35944359
[TBL] [Abstract] [Full Text] [Related]
16. Identification and characterization of FGFR2
Qiu H; Zhang X; Qi J; Zhang J; Tong Y; Li L; Fu L; Qin YR; Guan X; Zhang L
J Exp Clin Cancer Res; 2022 Aug; 41(1):240. PubMed ID: 35941662
[TBL] [Abstract] [Full Text] [Related]
17. Poor Prognosis of Oral Squamous Cell Carcinoma Correlates With ITGA6.
Zhang C; Cai Q; Ke J
Int Dent J; 2023 Apr; 73(2):178-185. PubMed ID: 35820930
[TBL] [Abstract] [Full Text] [Related]
18. Comparative evaluation of somatostatin and cxcr4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies.
Czajkowski M; Kaemmerer D; Sänger J; Sauter G; Wirtz RM; Schulz S; Lupp A
BMC Cancer; 2022 Jul; 22(1):740. PubMed ID: 35799158
[TBL] [Abstract] [Full Text] [Related]
19. Ursolic acid inhibits proliferation, migration and invasion of human papillary thyroid carcinoma cells via CXCL12/cxcr4/CXCR7 axis through cancer-associated fibroblasts.
Cao X; He Q
Hum Exp Toxicol; 2022; 41():9603271221111333. PubMed ID: 35786050
[TBL] [Abstract] [Full Text] [Related]
20. Diagnostic Value of MRI Combined with cxcr4 Expression Level in Lymph Node Metastasis head and neck Squamous Cell Carcinoma.
Zhao J; Li X; Wang M; Liu F; Wang J
Comput Math Methods Med; 2022; 2022():4073918. PubMed ID: 35309836
[TBL] [Abstract] [Full Text] [Related]
[Next]
